These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7559728)

  • 1. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.
    Takeuchi T
    J Cancer Res Clin Oncol; 1995; 121(9-10):505-10. PubMed ID: 7559728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and antitumor antibiotics produced by microorganisms.
    Oki T
    Biotechnol Bioeng; 1980; 22 Suppl 1():83-97. PubMed ID: 6159010
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New microbial secondary metabolites under preclinical development for cancer treatment.
    Umezawa H
    Recent Results Cancer Res; 1978; 63():120-34. PubMed ID: 705007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
    Iwasawa H; Kondo S; Ikeda D; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Dec; 35(12):1665-9. PubMed ID: 6926749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peplomycin and liblomycin, a new analogues of bleomycin.
    Takita T; Ogino T
    Biomed Pharmacother; 1987; 41(5):219-26. PubMed ID: 2444281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discovery of the effect of bleomycin on squamous cell carcinoma and development of its research].
    Ichikawa A
    Nihon Ishikai Zasshi; 1969 Jul; 62(2):153-8. PubMed ID: 4899854
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor drugs and potentiators aiming circumvention of drug resistance].
    Suzuki H
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):335-41. PubMed ID: 1689986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxyspergualin: from cytostasis to immunosuppression.
    Dickneite G; Schorlemmer HU; Weinmann E; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):231-9. PubMed ID: 3044340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K; Goto T; Fukushima M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roots of modern oncology: from discovery of new antitumor anthracyclines to their clinical use.
    Cassinelli G
    Tumori; 2016 Jun; 2016(3):226-35. PubMed ID: 27103205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of deoxyspergualin in multidrug-resistant cells.
    Holmes JA; Twentyman PR
    Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo.
    Micallef M; Hosokawa M; Shibata T; Nakane A; Yang ZB; Minagawa T; Kobayashi H
    Cancer Immunol Immunother; 1991; 33(1):33-8. PubMed ID: 1708700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
    Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
    Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.